NCT06455709View on ClinicalTrials.gov

Markers of Favorable Response to Complement Inhibitors Therapy

RecruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions

Myasthenia Gravis, Generalized

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER